EN
0
Home > Products > Pharmaceuticals & Life Science > Pharmaceutical Intermediates > (4R)-4-((3R,5R,10R,13R)-6-ethylidene-3-hydroxy-10,13-dimethyl-7-oxohexadeca hydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid
(4R)-4-((3R,5R,10R,13R)-6-ethylidene-3-hydroxy-10,13-dimethyl-7-oxohexadeca hydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid structure, CAS 915038-24-3

(4R)-4-((3R,5R,10R,13R)-6-ethylidene-3-hydroxy-10,13-dimethyl-7-oxohexadeca hydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

CAS Number915038-24-3

Synonyms3α-hydroxy-6-ethyliden-7-keto-5β-cholanic acid

Molecular FormulaC26H40O4

Molecular Weight416.6

Purity

Density

Boiling Point

Melting Point

Flash Point

Appearance

EINECS

MSDSChineseEnglish

Symbol

Signal Word

Cat. No.: 2A-3179676 Purity:
Change View

Please Login or Create an Account to: See VlP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

Inquiry

Quality Control of [ 915038-24-3 ] SDS Specification MoL

COA NMR CNMR HPLC LC-MS
Chemical & Physical Properties
CAS Number915038-24-3
Catalog No.2A-3179676
Chinese Name(EZ)-3α-羟基-6-亚乙基-7-酮-5β-胆烷-24-酸
Synonyms3α-hydroxy-6-ethyliden-7-keto-5β-cholanic acid
Molecular FormulaC26H40O4
Molecular Weight416.6
PubChem ID342398034
MDL NumberMFCD28411244
InChIInChI=1S/C26H40O4/c1-5-17-21-14-16(27)10-12-26(21,4)20-11-13-25(3)18(15(2)6-9-22(28)29)7-8-19(25)23(20)24(17)30/h5,15-21,23,27H,1,6-14H2,2-4H3,(H,28,29)/t15-,16-,17?,18-,19+,20+,21+,23+,25-,26-/m1/s1
InChI KeyNNNCIQYLYWIMIU-JDNINRFJSA-N
Related Products in Pharmaceutical Intermediates
((1R,2R)-cyclohexane-1,2-diyl)bis(methylene) bis(4-(benzo[d] isothiazol-3-yl)piperazine-1-carboxylate)1807983-61-42A-3179631
(3aR,4R,7S,7aS)-rel-2-[[(1R,2R)-2-[[4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl]methyl]cyclohexyl]methyl]hexahydro-4,7-methano-1H-isoindole-1,3(2H)-dione hydrochloride (1:1)139563-24-92A-3179633
(R)-4-((3R,5S,6S,7S,10S,13R)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid1708092-13-02A-3179669
(R)-4-((3R,5S,6S,7R,10S,13R)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid915038-27-62A-3179672
(3R,5S,6R,7R,10S,13R)-6-ethyl-17-((R)-5-hydroxypentan-2-yl)-10,13-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthrene-3,7-diol1537866-49-12A-3179673
(4R)-4-[(3S,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid566-24-52A-3179679
(5Z)-N-(Cyclopropylmethyl)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3R)-3-hydroxy-4-phenoxy-1-buten-1-yl]cyclopentyl]-5-heptenamide1138395-09-12A-2179690
5-Bromo-3-nitro-1H-pyrrolo[2,3-b]pyridine507462-26-22A-3179720
4-(2'-N-BOC-HYDRAZINO)BENZOIC ACID96736-00-42A-3179733
N-FMoc-trans-4-Cyclohexyl-L-proline2A-21797762A-2179776
Browse all Pharmaceutical Intermediates products »
Contact Us

Phone:

630-322-8886

630-322-8887

Email:

[email protected]

Office Locations:

Chicago, IL, USA

San Francisco, CA, USA